Ju‐Sheng Lin

3.0k total citations · 1 hit paper
64 papers, 1.6k citations indexed

About

Ju‐Sheng Lin is a scholar working on Epidemiology, Molecular Biology and Hepatology. According to data from OpenAlex, Ju‐Sheng Lin has authored 64 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Epidemiology, 26 papers in Molecular Biology and 18 papers in Hepatology. Recurrent topics in Ju‐Sheng Lin's work include Hepatitis B Virus Studies (30 papers), Liver Disease Diagnosis and Treatment (13 papers) and Hepatitis C virus research (11 papers). Ju‐Sheng Lin is often cited by papers focused on Hepatitis B Virus Studies (30 papers), Liver Disease Diagnosis and Treatment (13 papers) and Hepatitis C virus research (11 papers). Ju‐Sheng Lin collaborates with scholars based in China, United States and Italy. Ju‐Sheng Lin's co-authors include Xingxing He, Ying Chang, Chuanrui Xu, Shuzhen Sun, Dong Xu, Yung‐Chi Cheng, Jiazhi Liao, Chung K. Chu, John C. Drach and Jiří Žemlička and has published in prestigious journals such as PLoS ONE, Cancer Research and Biochemical and Biophysical Research Communications.

In The Last Decade

Ju‐Sheng Lin

62 papers receiving 1.6k citations

Hit Papers

Hepatogastroenterology 2012 2026 2016 2021 2012 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ju‐Sheng Lin China 16 521 472 385 361 298 64 1.6k
Dalbir S. Sandhu United States 18 419 0.8× 473 1.0× 281 0.7× 304 0.8× 193 0.6× 50 1.4k
Mee Soo Chang South Korea 26 515 1.0× 460 1.0× 721 1.9× 744 2.1× 306 1.0× 106 2.2k
Norihiko Yamamoto Japan 25 591 1.1× 217 0.5× 295 0.8× 371 1.0× 109 0.4× 66 1.6k
Po‐Min Chen Taiwan 23 500 1.0× 283 0.6× 252 0.7× 705 2.0× 243 0.8× 87 1.9k
Linda A. Lee United States 21 1.8k 3.4× 281 0.6× 329 0.9× 513 1.4× 286 1.0× 58 3.1k
Takeshi Todoroki Japan 28 484 0.9× 1.1k 2.3× 177 0.5× 869 2.4× 581 1.9× 88 2.2k
J Piris United Kingdom 26 428 0.8× 910 1.9× 654 1.7× 820 2.3× 319 1.1× 54 2.8k
Kazuo Hatsuse Japan 19 403 0.8× 358 0.8× 337 0.9× 603 1.7× 287 1.0× 53 1.5k
Jianmin Wang China 26 820 1.6× 163 0.3× 380 1.0× 700 1.9× 131 0.4× 141 2.7k
Volker Ellenrieder Germany 21 519 1.0× 572 1.2× 405 1.1× 558 1.5× 334 1.1× 111 1.7k

Countries citing papers authored by Ju‐Sheng Lin

Since Specialization
Citations

This map shows the geographic impact of Ju‐Sheng Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ju‐Sheng Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ju‐Sheng Lin more than expected).

Fields of papers citing papers by Ju‐Sheng Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ju‐Sheng Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ju‐Sheng Lin. The network helps show where Ju‐Sheng Lin may publish in the future.

Co-authorship network of co-authors of Ju‐Sheng Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Ju‐Sheng Lin. A scholar is included among the top collaborators of Ju‐Sheng Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ju‐Sheng Lin. Ju‐Sheng Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Man, Yao Liu, Patrick R. Varley, et al.. (2015). High-Mobility Group Box 1 Promotes Hepatocellular Carcinoma Progression through miR-21–Mediated Matrix Metalloproteinase Activity. Cancer Research. 75(8). 1645–1656. 78 indexed citations
2.
He, Xingxing, Shuzhen Kuang, Jiazhi Liao, et al.. (2014). The regulation of microRNA expression by DNA methylation in hepatocellular carcinoma. Molecular BioSystems. 11(2). 532–539. 60 indexed citations
3.
Yan, Jingjun, Jiazhi Liao, Ju‐Sheng Lin, & Xingxing He. (2014). Active radar guides missile to its target: receptor-based targeted treatment of hepatocellular carcinoma by nanoparticulate systems. Tumor Biology. 36(1). 55–67. 29 indexed citations
4.
He, Xingxing, An‐Yuan Guo, Chuanrui Xu, et al.. (2014). Bioinformatics analysis identifies miR-221 as a core regulator in hepatocellular carcinoma and its silencing suppresses tumor properties. Oncology Reports. 32(3). 1200–1210. 44 indexed citations
5.
Chen, Man, Ying Chang, Jin Li, et al.. (2013). Influence of cytotoxic T lymphocyte-associated antigen 4 polymorphisms on the outcomes of hepatitis B virus infection. Molecular Medicine Reports. 9(2). 645–652. 11 indexed citations
6.
He, Xingxing, Yang Hong, Jin Li, et al.. (2012). Association of a TANK Gene Polymorphism with Outcomes of Hepatitis B Virus Infection in a Chinese Han Population. Viral Immunology. 25(1). 73–78. 11 indexed citations
7.
Hong, Yang, Xingxing He, Man Chen, et al.. (2012). Association of Ephrin receptor A3 gene polymorphism with susceptibility to chronic severe hepatitis B. Hepatology Research. 42(8). 790–797. 4 indexed citations
8.
Wang, Zhijun, Fang Liu, Wei Tu, et al.. (2011). Embryonic liver fodrin involved in hepatic stellate cell activation and formation of regenerative nodule in liver cirrhosis. Journal of Cellular and Molecular Medicine. 16(1). 118–128. 19 indexed citations
9.
Liu, Lifeng, Li Jin, Jinjian Yao, et al.. (2011). A Genome-Wide Association Study with DNA Pooling Identifies the Variant rs11866328 in the GRIN2A Gene That Affects Disease Progression of Chronic HBV Infection. Viral Immunology. 24(5). 397–402. 19 indexed citations
10.
Liu, Lifeng, Jinjian Yao, Jin Li, et al.. (2011). Effects of variant rs346473 in ARHGAP24 gene on disease progression of HBV infection in han Chinese population. Journal of Huazhong University of Science and Technology [Medical Sciences]. 31(4). 482–487. 3 indexed citations
11.
He, Xingxing, Ying Chang, Fanying Meng, et al.. (2010). Persistent Effect of IFNAR-1 Genetic Polymorphism on the Long-Term Pathogenesis of Chronic HBV Infection. Viral Immunology. 23(3). 251–257. 28 indexed citations
12.
Hu, Xiaowen, Ju‐Sheng Lin, Jinghua Ren, et al.. (2010). DNA double-strand breaks, potential targets for HBV integration. Journal of Huazhong University of Science and Technology [Medical Sciences]. 30(3). 265–270. 8 indexed citations
13.
He, Xingxing, Ju‐Sheng Lin, Ying Chang, et al.. (2008). Effects of two novel nucleoside analogues on different hepatitis B virus promoters. World Journal of Gastroenterology. 14(12). 1836–1836. 1 indexed citations
14.
He, Xingxing, Ting Chen, Ju‐Sheng Lin, Ying Chang, & Baixin Ye. (2008). Inhibition of the replication of hepatitis B virus in vitro by a novel 2,6-diaminopurine analog, β-LPA. Biochemical and Biophysical Research Communications. 369(2). 513–518. 7 indexed citations
15.
Wang, Xiaoyan, Linlin Gao, Fēi Dèng, et al.. (2007). High-level production of a functional recombinant hepatitis B virus polymerase in insect cells with a baculovirus expression system. Journal of Huazhong University of Science and Technology [Medical Sciences]. 27(3). 269–273. 1 indexed citations
16.
Lin, Ju‐Sheng, et al.. (2006). [Relationship between death receptor 5 and apoptosis in hepatocellular carcinoma].. PubMed. 28(4). 261–4. 1 indexed citations
17.
Ren, Jinghua, Ju‐Sheng Lin, Xu D, et al.. (2006). Screening of efficient siRNA target sites directed against gatekeeper genes for DNA repair. Journal of Huazhong University of Science and Technology [Medical Sciences]. 26(6). 640–643. 2 indexed citations
18.
Lin, Ju‐Sheng, et al.. (2003). [Correlation between polymorphism of TaqI of ET-1 gene and cirrhotic portal hypertension].. PubMed. 83(6). 463–6. 1 indexed citations
19.
Lin, Ju‐Sheng. (2003). Preparation and identification of anti-transforming growth factor β1 U1 small nuclear RNA chimeric ribozymein vitro. World Journal of Gastroenterology. 9(3). 572–572. 7 indexed citations
20.
Wu, Jin‐Ming, et al.. (2003). [Inhibition of the replication of hepatitis B virus in vitro by a novel nucleoside analogue (beta-L-D4A)].. PubMed. 11(7). 446–446.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026